Periscope Capital’s Biote Corp. Warrant BTMDW Stock Holding History

Periscope Capital’s Portfolio BTMDW Stock Details BTMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-90,600	Closed	-$50K	–	1254
2022 Q1	$50K	Sell	90,600 -1,800	-2%	-$854	﹤0.01%	948
2021 Q4	$66K	Sell	92,400 -44,900	-33%	-$36.2K	﹤0.01%	890
2021 Q3	$113K	Buy	+137,300	New	+$122K	﹤0.01%	756

Other funds holding BTMDW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

BCM

BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

SRF

Silver Rock Financial Los Angeles, California $49.7M AUM 17.42% 1-Year Est. Return

Periscope Capital's BTMDW Position: Q2 2022 in Review

Periscope Capital sold out of Biote Corp. Warrant (BTMDW) in Q2 2022, closing a stake of 90,600 shares — an estimated $50K sold.

Periscope Capital first reported a position in BTMDW in Q3 2021 and held it in 3 quarters. The position peaked at $113K in Q3 2021. 42 funds tracked by Wall St. Rank hold BTMDW as of Q2 2022.

Periscope Capital reported no remaining Biote Corp. Warrant position as of Q2 2022 after selling out during the quarter.
Periscope Capital sold 90,600 Biote Corp. Warrant shares in Q2 2022, an estimated $50K.
Periscope Capital first reported a position in Biote Corp. Warrant in Q3 2021 and held it in 3 quarters.
Periscope Capital's Biote Corp. Warrant position peaked at $113K in Q3 2021.
42 funds tracked by Wall St. Rank held Biote Corp. Warrant as of Q2 2022.

Based on Periscope Capital's 13F filing for Q2 2022, filed 15 Aug 2022.